A Bird's Eye View Of Eagle Pharma

Shares of Eagle Pharmaceuticals Inc. (EGRX) are down 67% from their 52-week high of $40.85, recorded last November, and trade around $13..

Related Keywords

Japan ,Teva Pharma ,Eagle Pharmaceuticals Inc ,Nasdaq ,Centers For Medicare Medicaid Services ,Cephalon Inc ,Symbio Pharmaceuticals Ltd ,Eagle Pharmaceuticals ,Chronic Lymphocytic Leukemia ,Non Small Cell Lung Cancer ,Malignant Pleural ,Medicaid Services ,Scott Tarriff ,Chief Executive Officer ,Eagle Pharma ,Symbio Pharmaceuticals ,New Drug Application ,Fda ,Leukemia ,Mesothelioma ,